A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis - Schiele, F; Vuillemot, A; Kramarz, P; Kieffer, Y; Soria, J; Soria, C; Camez, A; Misrahi, MC; Bassand, JP (Thromb Haemost, 1994)